Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 4 Interventional Results available

Safety and Efficacy Study of Abraxane in Combination With Carboplatin to Treat Advanced NSCL Cancer in the Elderly

ClinicalTrials.gov ID: NCT02151149

Public ClinicalTrials.gov record NCT02151149. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 5, 2026, 1:44 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Safety and Efficacy of Nab-paclitaxel (Abraxane) in Combination With Carboplatin as First Line Treatment in Elderly Subjects With Advance Non-Small Cell Lung Cancer (NSCLC): A Phase IV, Randomized, Open-Label, Multicenter Study (Abound.70+)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

Study comparing two regimens of nab-paclitaxel and carboplatin combination in elderly subjects (≥ 70 years old) with advanced NSCLC

Study identification

NCT ID
NCT02151149
Recruitment status
Completed
Study type
Interventional
Phase
Phase 4
Lead sponsor
Celgene
Industry
Enrollment
143 participants

Conditions and interventions

Eligibility (public fields only)

Age range
70 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jun 8, 2014
Primary completion
Jul 13, 2017
Completion
Jul 13, 2017
Last update posted
Sep 23, 2018

2014 – 2017

United States locations

U.S. sites
55
U.S. states
24
U.S. cities
53
Facility City State ZIP Site status
Arizona Clinical Research Center Tucson Arizona 85715
Genesis Cancer Center Hot Springs Arkansas 71913
Comprehensive Blood and Cancer Center Bakersfield California 93309
Saint Jude Heritage Medical Center Fullerton California 92835
Global Cancer Research Institute (GCRI), Inc. Gilroy California 95020
Ventura County Hematology-Oncology Specialists Oxnard California 93030
Central Coast Medical Oncology Corporation Santa Maria California 93454
University of California Los Angeles Santa Monica California 90404
Rocky Mountain Cancer Centers, LLP Denver Colorado 80218
St Mary's Hospital and Regional Medical Center Grand Junction Colorado 81501
Lynn Cancer Institute Boca Raton Florida 33486
Baptist Cancer Inst Jacksonville Florida 32207
Ocala Oncology Center Ocala Florida 34471
Florida Hospital Cancer Institute Orlando Florida 32804
Northshore University Healthsystem Research Institute Evanston Illinois 60201
Oncology Specialists, S.C. Niles Illinois 60714
Franciscan St. Francis Health Indianapolis Indiana 46237
Cancer Center of Kansas Wichita Kansas 67214
Western Kentucky Hematology and Oncology Group Paducah Kentucky 42003
West Jeffersion Medical Center Marrero Louisiana 70072
Ochsner Medical Institutions New Orleans Louisiana 70123
Medstar Health Research Institute Baltimore Maryland 21237
Reliant Medical Group Worcester Massachusetts 01608
Henry Ford Health System Detroit Michigan 48202-268
Nebraska Methodist Hospital Omaha Nebraska 68114
Dartmouth Hitchcock Medical Center Lebanon New Hampshire 03756
Center for Cancer and Hematologic Disease Cherry Hill New Jersey 08003
Regional Cancer Care Associates LLC East Brunswick New Jersey 08816
Saint Barnabas Medical Center Livingston New Jersey 07039
Carol G Simon Cancer Center Morristown New Jersey 07962
Somerset Hematology-Oncology Associates Somerville New Jersey 08876
Regional Cancer Care Associates LLC- Sparta division Sparta New Jersey 07871
Brookdale University Hospital and Medical Center Brooklyn New York 11212
Broome Oncology, LLC Johnson City New York 13790
Clinical Research Alliance Lake Success New York 11042
SUNY Upstate Medical University Medicine Oncology Syracuse New York 13215
Montefiore Medical Center The Bronx New York 10461
Lineberger Cancer Center Chapel Hill North Carolina 27599
Levine Cancer Institute Charlotte North Carolina 28204
Forsyth Memorial Hospital, Inc. Winston-Salem North Carolina 27103
St Elizabeth Hospital Youngstown Ohio 44501
Cancer Centres of Southwest Okahoma Research Lawton Oklahoma 73505
Good Samaritan Hospital Corvalis Corvallis Oregon 97330
Oregon Health and Science University Portland Oregon 97210
Penn State Milton S Hershey Medical Center Hershey Pennsylvania 17033
Perelman Center for Advanced Medicine Philadelphia Pennsylvania 19104
Thomas Jefferson University Medical College Philadelphia Pennsylvania 19107
Fox Chase Cancer Center Philadelphia Pennsylvania 19111
Allegheny General Hospital Pittsburgh Pennsylvania 15212
Texas Oncology, P.A.-Amarillo Amarillo Texas 79106
Baylor University Medical Center at Dallas Dallas Texas 75246
UTMB Galveston Galveston Texas 77555-0565
Texas Oncology, PA - Longview Longview Texas 75601
Virginia Mason Cancer Center Seattle Washington 98101
Northwest Cancer Specialists, P.C. Vancouver Washington 98684

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02151149, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Sep 23, 2018 · Synced Sep 5, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT02151149 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →